PMLS Virtual Series 2021 – Precision Diagnostics for Precision Medicine Virtual Summit

To Register Click Here

May 11, 2021

10:00-10:30am EST

Keynote

TBD

10:35-11:00am  EST

Precision 20

TBD

11:05-11:55am  EST

Panel Discussion

TBD

12:00-12:25am  EST 

Precision 20

TBD

12:30-1:15pm    EST

Factors Influencing the Acceptance of a Novel Diagnostic Technology in the Coverage Policy of a Health Care Plan: Case Study

Mark D. Hiatt, MD, MBA, MS, Vice President, Medical Affairs, Guardant Health; Eugean Jiwanmall, MBA, MPH
Senior Research Analyst, Medical Policy & Technology Evaluation, Independence Blue Cross

This study of one plan’s evaluation and ultimate acceptance of liquid biopsy, in the context of ascertaining the genomic drivers of lung cancer, will illustrate the factors influencing such coverage decisions. Factors discussed include (a) published studies in support of the technology, (b) the description of the technology, and (c) the opinion of other plans and their intermediaries.

1:20-2:05pm      EST

Panel Discussion

TBD

2:10-2:55pm      EST 

Panel Discussion

TBD